Courtenay Harris Bond

courtenay harris bond

Courtenay Harris Bond is the staff writer covering health for PhillyVoice. She enjoys writing about behavioral health, maternal health and inequities in the healthcare system, as well as human rights and criminal justice. A veteran daily newspaper reporter, Courtenay has also written for national outlets, including KFF Health News, Undark Magazine and Filter. She was a 2018 Rosalynn Carter Fellow for Mental Health Journalism and has master's degrees from Columbia Journalism School and the University of Pennsylvania's Graduate School of Education.

courtenay@phillyvoice.com

November 18, 2026

Mental Health

Young adults are having a harder time coping with uncertainty, study shows

Young adults have become less tolerant of uncertainty in recent years, and this may be contributing to increases in anxiety disorders, new research shows.

November 18, 2026

Fitness

How to recover from a marathon, from the immediate fatigue to the muscle soreness that persists for days

Dr. John Luksch, of Rothman Orthopaedics, offers advice for recovering from a marathon, from what to do immediately after crossing the finish line to how to handle the muscle soreness that follows in the days after the race.

November 18, 2026

Senior Health

Persistant loneliness linked to higher risk of dementia

Persistant loneliness is associated with a significantly increased risk of dementia, a new study says. The research also found that occasional loneliness is not a risk factor for dementia.

November 17, 2026

Illness

Flu season started earlier than usual, but it's not too late to get vaccinated

Flu activity is rising earlier than usual, both in the Philadelphia region and nationwide. Health experts recommend all people 6 months and older get a flu shot to guard against infection.

November 12, 2026

Prevention

American Cancer Society recommends more aggressive prostate cancer screening

The American Cancer Society now recommends all men ages 50 to 69 receive prostate cancer screenings every two years. The new guidelines are a marked change from past advice, which left doctors and patients to decide when it was best to begin screening.

November 12, 2026

Mental Health

Trump administration invests $4.9 million to research psychedelic as PTSD treatment

The Trump administration is investing $4.9 million into studying the psychedelic ibogaine as a potential treatment for PTSD and other serious mental health issues. The drug has shown potential, but it also carries risk of abnormal heart rhythms and death.

November 11, 2026

Depression

Antidepressants Lexapro and Cymbalta may offer more enduring relief than Prozac, new study says

Some antidepressants offer more sustained relief than the commonly prescribed Prozac, new study says. But finding the best medication for each person requires balancing benefits and side effects, researchers note.

November 10, 2026

Health News

GLP-1 drugs must now carry warning labels about rare risk of vision loss

FDA is now requiring GLP-1 weight-loss drugs to include warning information about the rare potential for vision loss. The mandate follows a review of available research and patient complaints, but the FDA did not find a direct cause-and-effect relationship between GLP-1s and vision loss.

November 10, 2026

Illness

Flu shots show early promise as a potential skin cancer treatment

Directly injecting flu shots into melanoma tumors appears to disrupt the production of cancer cells, a new study shows. Researchers aren't sure why, but they say their findings are promising.

November 6, 2026

Children's Health

More babies may outgrow peanut allergy than previously thought, study finds

New research adds to a growing body of evidence that introducing peanuts early to babies may help prevent allergies. The study found as many as 35% of babies outgrow their peanut allergies.

All PhillyVoice contributors